Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 314, Issue 1, pp 61–66 | Cite as

The contribution of α1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man

  • Maria Brinkschulte
  • Ursula Breyer-Pfaff
Article

Summary

Parameters for the binding of perazine (PER), amitriptyline (AT) and nortriptyline (NT) to plasma and to single plasma proteins were determined by equilibrium dialysis. The highest affinity (K at least 105 M−1) and lowest capacity (first site 1 mol/mol) towards all three drugs was exhibited by α1-acid glycoprotein (α1-AGP). From the parameters, α1-AGP was estimated to contribute 43% to total binding of PER and 49 and 31%, respectively, to AT and NT binding in samples with normal protein concentrations. Fractions bound to total lipoproteins would amount to 32% (PER), 40% (AT) and 52% (NT), respectively, while the contribution of albumin would range from 11% (AT) to 25% (PER). The extent of the binding to plasma was compared with that to single proteins and their mixtures. Binding to combinations of α1-AGP, lipoproteins and albumin exceeded that to plasma with PER, but not with AT and NT. This leads to the assumption that additional plasma constitutents interfere with PER binding.

Key words

Tricyclic antidepressants Perazine Protein binding α1-Acid glycoprotein Lipoproteins 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bickel MH (1975) Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components. J Pharm Pharmacol 27:733–738Google Scholar
  2. Borgå O, Piafsky, KM, Nilsen OG (1977) Plasma protein binding of basic drugs. I. Selective displacement from α1-acid glycoprotein by tris(2-butoxyethyl)phosphate. Clin Pharmacol Ther 22:539–549Google Scholar
  3. Bowmer CJ, Lindup WE (1978) Binding of phenytoin, l-tryptophan and O-methyl red to albumin. Unexpected effect of albumin concentration on the binding of phenytoin and l-tryptophan. Biochem Pharmacol 27:937–942Google Scholar
  4. Brinkschulte M, Breyer-Pfaff U (1979) Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals. Naunyn-Schmiedeberg's Arch Pharmacol 308:1–7Google Scholar
  5. Brinkschulte M, Breyer-Pfaff U (1980) The role of lipoproteins in the binding of tricyclic antidepressants and perazine to human plasma. Proceedings of the 4th International Symposium on Phenothiazines and Related Drugs. North Holland Elsevier, Amsterdam, pp 189–193Google Scholar
  6. Brinkschulte M, Gaertner HJ, Schied HW (1980) The binding of amitriptyline and perazine to plasma proteins of patients and healthy subjects. Naunyn-Schmiedeberg's Arch Pharmacol 311:(Suppl) R74Google Scholar
  7. Cohn EJ, Hughes WL, Weare JH (1947) Preparation and properties of serum and plasma proteins. XIII. Crystallization of serum albumin from ethanol-water mixtures. J Am Chem Soc 69:1753–1761Google Scholar
  8. Danon A, Chen Z (1979) Binding of imipramine to plasma proteins: Effect of hyperlipoproteinemia. Clin Pharmacol Ther 25:316–321Google Scholar
  9. Doumas BT, Watson W, Biggs HG (1971) Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 31:87–96Google Scholar
  10. Glasson S, Zini R, d'Athis P, Tillement JP, Boissier Jr (1980) The distribution of bound propranolol between the different human serum proteins. Mol Pharmacol 17:187–191Google Scholar
  11. Goldstein A (1949) The interaction of drugs and plasma proteins. Pharmacol Rev 1:102–165Google Scholar
  12. Hulshoff A, Perrin JH (1977) Quantitative correlations between albumin binding constants and chromatographic RM values of phenothiazine derivatives. J Med Chem 20:430–439Google Scholar
  13. Klotz M, Hunston DL (1971) Properties of graphical representations of multiple classes of binding sites. Biochemistry 10:3065–3069Google Scholar
  14. Koch-Weser J, Sellers EM (1976) Binding of drugs to serum albumin New Engl J Med 294:311–316 and 526–531Google Scholar
  15. Krieglstein J, Meiler W, Staab J (1972) Hydrophobic and ionic interactions of phenothiazine derivatives with bovine serum albumin. Biochem Pharmacol 21:985–997Google Scholar
  16. Miese H, Müller WE, Wollert U (1978) The influence of increasing albumin concentrations on the determination of the binding of sulfamethoxy-pyridazine to human and bovine serum albumin. Arch Int Pharmacodyns 236:18–26Google Scholar
  17. Nilsen OG, Leren P, Aakesson I, Jacobsen S (1978) Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol 27:871–876Google Scholar
  18. Piafsky KM, Borgå O (1977) Plasma protein binding of basic drugs. II. Importance of α1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 22:545–549Google Scholar
  19. Piafsky KM, Borgå O, Odar-Cederlöf I, Johansson C, Sjöqvist F (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevation of plasma α1-acid glycoprotein. New Engl J Med 229:1435–1439Google Scholar
  20. Rudel LL, Lee JA, Morris MD, Felts JM (1974) Characterization of plasma lipoproteins separated and purified by agarose-column chromatography. Biochem J 139:89–95Google Scholar
  21. Scanu AM, Edelstein C, Keim P (1975) Serum lipoproteins. In: Putman FW (ed) The plasma proteins. Academic Press, New York, p 317Google Scholar
  22. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672Google Scholar
  23. Schley J, Nündel M, Riedel E, Müller-Oerlinghausen B (1979) Eine spezifische Serumproteinbindung des Neuroleptikums Perazin. Arzneim-Forsch (Drug Res) 29:106–108Google Scholar
  24. Schley J, Nündel M, Siegert M, Riedel E, Müller-Oerlinghausen B (1980) High affinity binding of perazine and desmethylperazine to human α1-acid glycoprotein. Pharmakopsychiatry 13:144–145Google Scholar
  25. Schmid K (1953) Preparation and properties of serum and plasma proteins. XXIX. Separation from human plasma of polysaccharides, peptides and proteins of low molecular weight. Crystallization of an acid glycoprotein. J Am Chem Soc 75:60–68Google Scholar
  26. Sharples D (1976) Factors affecting the binding of tricyclic tranquillizers and antidepressants to human albumin. J Pharm Pharmacol 28:100–105Google Scholar
  27. Vallner JJ (1977) Binding of drugs by albumin and plasma protein. J Pharm Sci 66:447–465Google Scholar
  28. Wieland H, Seidel D (1978) Fortschritte in der Analytik des Lipoproteinmusters. Inn Med 7:280–300Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • Maria Brinkschulte
    • 1
  • Ursula Breyer-Pfaff
    • 1
  1. 1.Institut für ToxikologieUniversität TübingenTübingenFederal Republic of Germany

Personalised recommendations